If you take this medicine, call your doctor now, says FDA
This is not the first time this common ordinance has been drawn from the market this year.
With regard to improving your overall well-being, finding the right prescription medicine to treat your health problems can be a serious game changer. And although many medications are associated with minor side effects to users, others can be a more serious and immediate threat to prescribing them. This has just been the case with a medicine by Pfizer, which is now subjected to its second reminder this summer on the possible health risks it can present. Read to find out if a medicine you are taking is subjected to the reminder and what to do if you have the medicine affected at home.
RELATED:If you take this medicine, stop now, says FDA.
The FDA has just announced the recall of four lots of Chantix.
On August 16, the FDA announced that Pfizer had voluntarilyrecalled four many Chantix, a medicine used to help patients stop smoking.
Recall-affected drugs include 56 Chantix 0.5 mg tablet accounts, cylinders of 56 Chantix 1 mg tablet accounts and cardboard boxes containing 0.5 mg blasters of CHANTIX tablets and 1 mg of Chantix tablets. Photos of newly recalled drugs, which were distributed in the United States and Puerto Rico between June 2019 and 2021, can be found on the FDA website.
For the latest reminder news delivered directly to your inbox,Sign up for our daily newsletter.
Many many Chantix were recalled in July.
This is not the first time Chantix has beenSubject to a reminder These last months. On July 19, the FDA announced that Pfizer hadrecalled two many chances Tablets of 0.5 mg, two of many Chantix 1 mg tablets and eight pleasted packaging included a combination of 0.5 mg chantix tablets and 1 mg tablets.
The complete list of lot numbers, expiry dates and NDC numbers for recalled requirements in July are on the FDA website.
The drug can contain an ingredient that can cause serious health problems.
According to the notice of reminder, the drug is recalled because of the presence of n-nitroso-varenicline, a type of nitrosamine, which exceeds the acceptable daily admission threshold (ADI) dictated by Pfizer.
"N-nitroso-vreanicine ingestion can be associated with theoretical potential at the risk of increasing cancer in humans, but there is no immediate risk for patients taking this medicine," Recall notice stipule. The booth of Chantix in July was linked to the same potential concerns of contamination.
If you take this medicine, talk to your doctor immediately.
If you take Chantix, talk to your doctor as soon as possible to determine if your medicine is affected by the reminder. However, the recall advice explains that the continuous treatment of Chantix can always be on the table for some patients. "The benefits of health to stop smoking exceed the risk of cancer of the theoretical potential of the impurity of nitrosamine in varedicin", according to the notice of reminder.
That said, Pfizer recommends that all the wholesalers or distributors of Chantix with the drugs recalled in their possession stop distributing the drug and quarantining the product to prevent the future access of the patient. If your medicine is about reminding, you can call Sterryycle Inc. At 888-276-6166 weekdays from 8h to 5 hours. To find out how to properly return the drug and how you can search for a refund.
RELATED:If you bought these supplements, stop using them immediately, says FDA.
